Secor Capital Advisors’s Halozyme HALO Stock Holding History

Secor Capital Advisors’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-123,999	Closed	-$1.81M	–	482
2018 Q4	$1.81M	Buy	123,999 +101,612	+454%	+$1.62M	0.24%	125
2018 Q3	$407K	Buy	+22,387	New	+$392K	0.04%	339
2018 Q2	–	Sell	-119,602	Closed	-$2.34M	–	554
2018 Q1	$2.34M	Buy	+119,602	New	+$2.32M	0.19%	178
2017 Q4	–	Sell	-109,093	Closed	-$1.9M	–	532
2017 Q3	$1.9M	Buy	109,093 +14,906	+16%	+$202K	0.18%	179
2017 Q2	$1.21M	Buy	+94,187	New	+$1.26M	0.11%	251
2017 Q1	–	Sell	-154,941	Closed	-$1.53M	–	511
2016 Q4	$1.53M	Buy	+154,941	New	+$1.7M	0.19%	164
2016 Q3	–	Sell	-53,638	Closed	-$463K	–	579
2016 Q2	$463K	Buy	+53,638	New	+$529K	0.06%	419

Other funds holding HALO

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Secor Capital Advisors's HALO Position: Q1 2019 in Review

Secor Capital Advisors sold out of Halozyme (HALO) in Q1 2019, closing a stake of 123,999 shares — an estimated $1.81M sold.

Secor Capital Advisors first reported a position in HALO in Q2 2016 and held it in 7 quarters. The position peaked at $2.34M in Q1 2018. 201 funds tracked by Wall St. Rank hold HALO as of Q1 2019.

Secor Capital Advisors reported no remaining Halozyme position as of Q1 2019 after selling out during the quarter.
Secor Capital Advisors sold 123,999 Halozyme shares in Q1 2019, an estimated $1.81M.
Secor Capital Advisors first reported a position in Halozyme in Q2 2016 and held it in 7 quarters.
Secor Capital Advisors's Halozyme position peaked at $2.34M in Q1 2018.
201 funds tracked by Wall St. Rank held Halozyme as of Q1 2019.

Based on Secor Capital Advisors's 13F filing for Q1 2019, filed 15 May 2019.